Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOCARBAMOL Cause Urinary tract infection? 15 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Urinary tract infection have been filed in association with METHOCARBAMOL (Methocarbamol Tablets, USP, 500 mg). This represents 0.7% of all adverse event reports for METHOCARBAMOL.

15
Reports of Urinary tract infection with METHOCARBAMOL
0.7%
of all METHOCARBAMOL reports
0
Deaths
8
Hospitalizations

How Dangerous Is Urinary tract infection From METHOCARBAMOL?

Of the 15 reports, 8 (53.3%) required hospitalization, and 2 (13.3%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOCARBAMOL. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does METHOCARBAMOL Cause?

Drug ineffective (294) Completed suicide (277) Toxicity to various agents (166) Drug hypersensitivity (162) Drug dependence (130) Drug abuse (121) Hypertension (119) Off label use (105) Respiratory depression (104) Nausea (95)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which METHOCARBAMOL Alternatives Have Lower Urinary tract infection Risk?

METHOCARBAMOL vs METHOHEXITAL METHOCARBAMOL vs METHOTREXATE METHOCARBAMOL vs METHOXSALEN METHOCARBAMOL vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOCARBAMOL vs METHYL ALCOHOL

Related Pages

METHOCARBAMOL Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection METHOCARBAMOL Demographics